Skip to main content

GoodRx Holdings, Inc. (GDRX)

NASDAQ: GDRX · Delayed Price · USD
40.10
3.28 (8.91%)
At close: Nov 29, 2021 4:00 PM
40.25
0.15 (0.37%)
Pre-market:Nov 30, 2021 4:03 AM EST

Company Description

GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.

The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.

It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.

GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.

GoodRx Holdings, Inc.
CountryUnited States
IPO DateSep 23, 2020
IndustryHealth Care Technology
SectorHealth Care
Employees450

Contact Details

Address:
2701 Olympic Boulevard
Santa Monica, CA 90404
United States
Phone855 268 2822
Websitegoodrx.com

Stock Details

Ticker SymbolGDRX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
IPO Price$33.00
CIK Code1809519

Key Executives

NamePosition
Douglas Joseph HirschCo-Chief Executive Officer and Director
Trevor BezdekCo-Chief Executive Officer, Secretary and Director
Andrew SlutskyPresident of Consumer
Bansi NagjiPresident of Healthcare
Karsten Ian VoermannChief Financial Officer
Whitney NotaroVice President of Investor Relations
Babak AzadChief Marketing Officer and SVice President of Marketing and Communications
Justin FenglerSenior Vice President of Corporate Strategy and Business Operations

Latest SEC Filings

DateTypeTitle
Nov 18, 20214Statement of changes in beneficial ownership of securities
Nov 12, 20214Statement of changes in beneficial ownership of securities
Nov 10, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 10, 20218-KCurrent report
Nov 5, 2021SC 13D/AGeneral statement of acquisition of beneficial ownership
Nov 3, 20214Statement of changes in beneficial ownership of securities
Nov 3, 20214Statement of changes in beneficial ownership of securities
Oct 26, 20214Statement of changes in beneficial ownership of securities
Oct 21, 20214Statement of changes in beneficial ownership of securities
Oct 13, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings